JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

REUTERS: Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AbbVie halts late-stage trial for lung cancer drug Rova-TREUTERS: AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Supernus Pharma's ADHD drug meets main goal in late-stage trialREUTERS: Supernus Pharmaceuticals Inc said on Thursday its drug for attention deficit hyperactivity disorder met the main goal in a late-stage ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trialEli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »